Anti-KOR-SA3544 (Human) mAb
Code | Size | Price |
---|
MBL-D028-3 | 100 ul | £323.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Isotype: IgG
Antibody Clonality: Monoclonal
Antibody Clone: KOR-SA3544
Regulatory Status: RUO
Target Species: Human
Applications:
- Flow Cytometry
- Western Blot (WB)
Shipping:
4°C
Storage:
-20°C. Please refer to datasheet for additional information
Images
Documents
Further Information
Applications:
WB - 10 ug/mL FCM - 10 ug/mL (final concentration)
Background:
This monoclonal antibody
(clone
KOR
-
SA3544
)
was react
ive with a surface antigen
expressed on Philadelphia chromosome (Ph
1
)
-
positive
acute lymphoblastic leukemia (ALL) without exception
(26/26 cases). The recognized antigen is a nonspecific
cross
-
reacting antigen (NCA)
-
50/90 (CD66c), one of the
carcinoembryon
ic antigen (CEA)
-
related glycoproteins
encoded by a member of the CEA gene family.
The Philadelphia chromosome (Ph
1
) has been implicated
as the causative factor in greater than 90% of chronic
myelogenous leukemia (CML), in 25
?
30% of adult and
2
?
10% of c
hildhood acute lymphoblastic leukemia (ALL)
and in rare cases of acute myelogenous leukemia (AML).
The presence of the Ph in leukemic cells of ALL patients
usually indicates poor prognosis and high risk. Sequential
monitoring of the Ph in ALL correlates wi
th the activity of
malignant clones and predicts impending clinical relapse,
and therefore is useful in guiding clinical therapeutic
decisions.
Formulation:
100 ug IgG in 100 uL volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained.
Gene IDs:
Human: 4986 Mouse: 18387
Immunogen Translated:
KOCL-22 myeloid cell line derived from congenital leukemia
Reactivity:
The reactivity of this antibody has been
reported as follows.
Common ALL
a
5/38
(13.2%)
Early B precursor ALL
b
1
c
/21
(4.8%)
T
-
ALL
0/19
B
-
ALL
0/6
B
-
CLL/HCL
0/3
Multiple myeloma
0/2 ANLL
16/56
(28.6%)
Ph1
-
ALL
26/26
d
(100%)
CML blastic crisis
0/9
T
-
NHL
0/5
B
-
NHL
0/4
Hodgkin's disease
0/1
CLL, chronic lymphocytic leukemia
HCL, hairy cell leukemia
NHL, non
-
Hodgkin's lymphoma
a
CD10
+
,
CD19
+
,
HLA
-
DR
+
b
CD10
-
,
CD19
+
,
HLA
-
DR
+
c
One patient with 11q23 translocation.
d
Ei
ghteen patients with m
-
bcr, eight patients with M
-
bcr
Shelf Life:
1 year
Source:
This antibody was purified from hybridoma
(clone KOR-SA3544) supernatant using protein A agarose.
This hybridoma was established by fusion of mouse
myeloma cell 63.Ag8.653/NS1 with Balb/c mouse
splenocyte immunized with a cell line (KOCL-22)
established from bone marrow blood of patient with
congenital leukemia.
Target:
KOR-SA3544
References
1)
Sugita, K.,
et al.,
Leukemia
13
,
779
-
785
(199
9
)
2)
Mori
,
T.,
et al.,
Leukem
i
a
9
, 1233
-
1239 (1995)
Clone KOR
-
SA3544 is used in these references.